REPL vs TXT · $825.7M cap vs P/E 19, rev $13.70B
Replimune Group Inc (REPL) versus Textron Inc (TXT) — a side-by-side from cached financials, not a winner call.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Textron Inc (TXT) is a aerospace & defense company listed on US.
REPL does not have a complete income-statement cache yet.
Latest reported TXT revenue for 2024-12-28 was $13.70B. Net income was $824.0M. Revenue was up 0.1% from 2023-12-30 to 2024-12-28. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
REPL currently screens at market cap $825.7M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
Not investment advice. Open the REPL and TXT stock pages for the full models.
Not investment advice.